Literature DB >> 15917517

New mutations and horizontal transfer of rpoB among rifampin-resistant Streptococcus pneumoniae from four Spanish hospitals.

María José Ferrándiz1, Carmen Ardanuy, Josefina Liñares, José María García-Arenzana, Emilia Cercenado, Ana Fleites, Adela G de la Campa.   

Abstract

A total of 103 (0.7%) of 14,236 Streptococcus pneumoniae isolates collected in four Spanish hospitals from 1989 to 2003 were resistant to rifampin (MICs, 4 to 512 microg/ml). Only sixty-one (59.2%) of these isolates were available for molecular characterization. Resistance was mostly related to human immunodeficiency virus (HIV) infection in adult patients and to conjunctivitis in children. Thirty-six different pulsed-field gel electrophoresis patterns were identified among resistant isolates, five of which were related to international clones (Spain23F-1, Spain6B-2, Spain9V-3, Spain14-5, and clone C of serotype 19F), and accounted for 49.2% of resistant isolates. Single sense mutations at cluster N or I of the rpoB gene were found in 39 isolates, while double mutations, either at cluster I, at clusters I and II, or at clusters N and III, were found in 14 isolates. The involvement of the mutations in rifampin resistance was confirmed by genetic transformation. Single mutations at clusters N and I conferred MICs of 2 microg/ml and 4 to 32 microg/ml, respectively. Eight isolates showed high degrees of nucleotide sequence variations (2.3 to 10.8%) in rpoB, suggesting a recombinational origin for these isolates, for which viridans group streptococci are their potential gene donors. Although the majority of rifampin-resistant isolates were isolated from individual patients without temporal or geographical relationships, the clonal dissemination of rifampin-resistant isolates was observed among 12 HIV-infected patients in the two hospitals with higher rates of resistance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917517      PMCID: PMC1140543          DOI: 10.1128/AAC.49.6.2237-2245.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  Emergence of rifampin-resistant Streptococcus pneumoniae as a result of antimicrobial therapy for penicillin-resistant strains.

Authors:  P M van Tilburg; D Bogaert; M Sluijter; A R Jansz; R de Groot; P W Hermans
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

2.  rpoB mutation conferring rifampin resistance in Streptococcus pyogenes.

Authors:  Hélène Aubry-Damon; Marc Galimand; Guy Gerbaud; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

3.  Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network.

Authors:  L McGee; L McDougal; J Zhou; B G Spratt; F C Tenover; R George; R Hakenbeck; W Hryniewicz; J C Lefévre; A Tomasz; K P Klugman
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

4.  Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

Authors:  G V Doern; K P Heilmann; H K Huynh; P R Rhomberg; S L Coffman; A B Brueggemann
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

5.  Prevalence of antimicrobial resistance in Streptococcus pneumoniae circulating in Italy: results of the Italian Epidemiological Observatory Survey (1997-1999).

Authors:  A Marchese; S Mannelli; E Tonoli; F Gorlero; M Toni; G C Schito
Journal:  Microb Drug Resist       Date:  2001       Impact factor: 3.431

6.  Sequencing of the rpoB gene in Legionella pneumophila and characterization of mutations associated with rifampin resistance in the Legionellaceae.

Authors:  K Nielsen; P Hindersson; N Hoiby; J M Bangsborg
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

7.  Molecular basis of rifampin resistance in Streptococcus pneumoniae.

Authors:  T Padayachee; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

8.  Structural mechanism for rifampicin inhibition of bacterial rna polymerase.

Authors:  E A Campbell; N Korzheva; A Mustaev; K Murakami; S Nair; A Goldfarb; S A Darst
Journal:  Cell       Date:  2001-03-23       Impact factor: 41.582

9.  Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis.

Authors:  J Martínez-Lacasa; C Cabellos; A Martos; A Fernández; F Tubau; P F Viladrich; J Liñares; F Gudiol
Journal:  J Antimicrob Chemother       Date:  2002-03       Impact factor: 5.790

10.  Genotypes of invasive pneumococcal isolates recently recovered from Italian patients.

Authors:  Giordano Dicuonzo; Giovanni Gherardi; Robert E Gertz; Fabio D'Ambrosio; Antonio Goglio; Giulia Lorino; Simona Recchia; Annalisa Pantosti; Bernard Beall
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

View more
  14 in total

1.  Evidence of localized prophage-host recombination in the lytA gene, encoding the major pneumococcal autolysin.

Authors:  María Morales; Pedro García; Adela G de la Campa; Josefina Liñares; Carmen Ardanuy; Ernesto García
Journal:  J Bacteriol       Date:  2010-03-19       Impact factor: 3.490

2.  New species genetic approach to identify strains of mitis group streptococci that are donors of rifampin resistance to Streptococcus pneumoniae.

Authors:  María-José Ferrándiz; Carmen Ardanuy; Josefina Liñares; Luz Balsalobre; María Teresa García; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

3.  Clinical Isolates of the Spain14-5 clone of Streptococcus pneumoniae carry a recombinant rpoB gene.

Authors:  M J Ferrándiz; E Pérez-Trallero; J M Marimón; A G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

4.  Activity of novel benzoxazinorifamycins against rifamycin-resistant Streptococcus pyogenes.

Authors:  Steve Mullin; David M Rothstein; Christopher K Murphy
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

5.  The genome of Streptococcus mitis B6--what is a commensal?

Authors:  Dalia Denapaite; Reinhold Brückner; Michael Nuhn; Peter Reichmann; Bernhard Henrich; Patrick Maurer; Yvonne Schähle; Peter Selbmann; Wolfgang Zimmermann; Rolf Wambutt; Regine Hakenbeck
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

6.  Frequency, spectrum, and nonzero fitness costs of resistance to myxopyronin in Staphylococcus aureus.

Authors:  Aashish Srivastava; David Degen; Yon W Ebright; Richard H Ebright
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

Review 7.  Rifampin combination therapy for nonmycobacterial infections.

Authors:  Graeme N Forrest; Kimberly Tamura
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

8.  Characterization of recombinant fluoroquinolone-resistant pneumococcus-like isolates.

Authors:  Luz Balsalobre; Montserrat Ortega; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

9.  Rapid pneumococcal evolution in response to clinical interventions.

Authors:  Nicholas J Croucher; Simon R Harris; Christophe Fraser; Michael A Quail; John Burton; Mark van der Linden; Lesley McGee; Anne von Gottberg; Jae Hoon Song; Kwan Soo Ko; Bruno Pichon; Stephen Baker; Christopher M Parry; Lotte M Lambertsen; Dea Shahinas; Dylan R Pillai; Timothy J Mitchell; Gordon Dougan; Alexander Tomasz; Keith P Klugman; Julian Parkhill; William P Hanage; Stephen D Bentley
Journal:  Science       Date:  2011-01-28       Impact factor: 47.728

10.  Significant variation in transformation frequency in Streptococcus pneumoniae.

Authors:  Benjamin A Evans; Daniel E Rozen
Journal:  ISME J       Date:  2013-01-10       Impact factor: 10.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.